Integrated Wealth Concepts’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$420K Sell
16,769
-26,995
-62% -$684K ﹤0.01% 1813
2026
Q2
$1.11M Buy
43,764
+3,482
+9% +$82.3K 0.01% 1158
2026
Q1
$910K Buy
+40,282
New +$895K 0.01% 1173

Other funds holding PCRX

Integrated Wealth Concepts's PCRX Position: Q3 2026 in Review

Integrated Wealth Concepts reduced its Pacira BioSciences (PCRX) stake by 62% in Q3 2026, selling an estimated $684K and leaving 16,769 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

Integrated Wealth Concepts first reported a position in PCRX in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.11M in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Integrated Wealth Concepts held 16,769 shares of Pacira BioSciences worth $420K as of Q3 2026.
  • Integrated Wealth Concepts sold 26,995 Pacira BioSciences shares in Q3 2026, an estimated $684K.
  • Pacira BioSciences made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q3 2026, its #1813 holding.
  • Integrated Wealth Concepts first reported a position in Pacira BioSciences in Q1 2026 and has held it in 3 quarters since.
  • Integrated Wealth Concepts's Pacira BioSciences position peaked at $1.11M in Q2 2026.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Integrated Wealth Concepts's 13F filing for Q3 2026, filed 17 Nov 2026.